Tabula Rasa HealthCare Inc
F:43T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (21.8), the stock would be worth €-1.44 (115% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -145.6 | €9.6 |
0%
|
| Industry Average | 21.8 | €-1.44 |
-115%
|
| Country Average | 21.9 | €-1.44 |
-115%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| US |
T
|
Tabula Rasa HealthCare Inc
F:43T
|
260.4m EUR | -145.6 | -58 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 88.6 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 36.2 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
25.5B USD | 20.3 | 30.9 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14B AUD | 119.5 | 60.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 23.5 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.2B SEK | 79.2 | 91.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 15.1 | 19.3 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.1B USD | 8.8 | 35.7 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
283.9B INR | -201.6 | 42.8 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.1B CNY | 80 | -62.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 21.9 |
| 70th Percentile | 36.5 |
| Max | 3 188 432.5 |
Other Multiples
Tabula Rasa HealthCare Inc
Glance View
Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. The company is headquartered in Moorestown, New Jersey and currently employs 1,602 full-time employees. The company went IPO on 2016-09-29. The Company’s segments include CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. The company accesses the market through a number of different service lines and brands, including CareKinesis, Capstone Risk Adjustment Services, CareVention Consulting, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides its clients, primarily health plans, and retail pharmacies. The company provides cloud-based patient engagement software and services and full-service clinical pharmacy programs. The company provides medication therapy management (MTM) software and services for Medicare, Medicaid, and commercial health plans.
